celastrol has been researched along with axitinib in 1 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (axitinib) | Trials (axitinib) | Recent Studies (post-2010) (axitinib) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 765 | 145 | 683 |
| Protein | Taxonomy | celastrol (IC50) | axitinib (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | 0.045 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.0658 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0079 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HG; Choi, JY; Jeong, JH; Kim, J; Kim, JO; Kim, JR; Kim, SY; Ku, SK; Ramasamy, T; Yong, CS; Youn, YS | 1 |
1 other study(ies) available for celastrol and axitinib
| Article | Year |
|---|---|
PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
Topics: Animals; Axitinib; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Imidazoles; Indazoles; Lipid Bilayers; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Pentacyclic Triterpenes; Porosity; Silicon Dioxide; Triterpenes | 2016 |